Back to search
FDAFDA · Food and drugs·Recall number D-0519-2019

BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) & b) 90 count (NDC 59746-758-90) bottles, Rx only, Manufactured b Jubilant Generis Ltd, Roorkee, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD

Published March 13, 2019 · Recall initiated: February 28, 2019

Summary

FDA records drug Class III recall D-0519-2019, published March 13, 2019 and initiated February 28, 2019. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: a) 3,072 bottles; b) 2,688 bottles; Lot: a) BR117002C, exp. date 11/2019; b) BR117003B and BR117004B, exp. date 11/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; 9-monthstability timepoint

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
Product was distributed to one customer who may have further distributed the product.
Lot
a) BR117002C, exp. date 11/2019; b) BR117003B and BR117004B, exp. date 11/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) & b) 90 count (NDC 59746-758-90) bottles, Rx only, Manufactured b Jubilant Generis Ltd, Roorkee, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD recalled?

Yes. FDA published recall D-0519-2019 on March 13, 2019. Reported hazard: Failed Dissolution Specifications; 9-monthstability timepoint

What should I do if I have this product?

Voluntary: Firm initiated · Letter